Kivipelto M - Search Results

1

27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial.

Sandebring-Matton A, Goikolea J, Björkhem I, Paternain L, Kemppainen N, Laatikainen T, Ngandu T, Rinne J, Soininen H, Cedazo-Minguez A, Solomon A, Kivipelto M. Sandebring-Matton A, et al. Among authors: kivipelto m. Alzheimers Res Ther. 2021 Mar 6;13(1):56. doi: 10.1186/s13195-021-00790-y. Alzheimers Res Ther. 2021. PMID: 33676572 Free PMC article. Clinical Trial.

2

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study.

Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. BMJ. 2001 Jun 16;322(7300):1447-51. doi: 10.1136/bmj.322.7300.1447. BMJ. 2001. PMID: 11408299 Free PMC article.

3

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.

Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Kivipelto M, et al. Neurology. 2001 Jun 26;56(12):1683-9. doi: 10.1212/wnl.56.12.1683. Neurology. 2001. PMID: 11425934

4

Hypertension and white matter lesions of the brain.

Kivipelto M, Soininen H, Tuomilehto J. Kivipelto M, et al. J Hypertens. 2002 Mar;20(3):387-9. doi: 10.1097/00004872-200203000-00011. J Hypertens. 2002. PMID: 11875303 Review. No abstract available.

5

Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.

Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Kivipelto M, et al. CNS Drugs. 2002;16(7):435-44. doi: 10.2165/00023210-200216070-00001. CNS Drugs. 2002. PMID: 12056919 Review.

6

Decreased brain creatine levels in elderly apolipoprotein E epsilon 4 carriers.

Laakso MP, Hiltunen Y, Könönen M, Kivipelto M, Koivisto A, Hallikainen M, Soininen H. Laakso MP, et al. Among authors: kivipelto m. J Neural Transm (Vienna). 2003 Mar;110(3):267-75. doi: 10.1007/s00702-002-0783-7. J Neural Transm (Vienna). 2003. PMID: 12658375

7

Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.

Tervo S, Kivipelto M, Hänninen T, Vanhanen M, Hallikainen M, Mannermaa A, Soininen H. Tervo S, et al. Among authors: kivipelto m. Dement Geriatr Cogn Disord. 2004;17(3):196-203. doi: 10.1159/000076356. Epub 2004 Jan 20. Dement Geriatr Cogn Disord. 2004. PMID: 14739544

8

Serum testosterone levels in males with Alzheimer's disease.

Pennanen C, Laakso MP, Kivipelto M, Ramberg J, Soininen H. Pennanen C, et al. Among authors: kivipelto m. J Neuroendocrinol. 2004 Feb;16(2):95-8. doi: 10.1111/j.0953-8194.2004.01133.x. J Neuroendocrinol. 2004. PMID: 14763994 Clinical Trial.

9

Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.

Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala EL, Vainio P, Vanninen R, Partanen K, Soininen H. Pennanen C, et al. Among authors: kivipelto m. Neurobiol Aging. 2004 Mar;25(3):303-10. doi: 10.1016/S0197-4580(03)00084-8. Neurobiol Aging. 2004. PMID: 15123335

10

Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study.

Anttila T, Helkala EL, Viitanen M, Kåreholt I, Fratiglioni L, Winblad B, Soininen H, Tuomilehto J, Nissinen A, Kivipelto M. Anttila T, et al. Among authors: kivipelto m. BMJ. 2004 Sep 4;329(7465):539. doi: 10.1136/bmj.38181.418958.BE. Epub 2004 Aug 10. BMJ. 2004. PMID: 15304383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page